Authors
B Orlikova, M Schnekenburger, Mire Zloh, F Golais, M Diederich, Deniz Tasdemir
Publication date
2012/9/1
Journal
Oncology reports
Volume
28
Issue
3
Pages
797-805
Publisher
Spandidos Publications
Description
Histone deacetylase enzymes (HDACs) are emerging as a promising biological target for cancer and inflammation. Using a fluorescence assay, we tested the in vitro HDAC inhibitory activity of twenty-one natural chalcones, a widespread group of natural products with well-known anti-inflammatory and antitumor effects. Since HDACs regulate the expression of the transcription factor NF-κB, we also evaluated the inhibitory potential of the compounds on NF-κB activation. Only four chalcones, isoliquiritigenin (no. 10), butein (no. 12), homobutein (no. 15) and the glycoside marein (no. 21) showed HDAC inhibitory activity with IC50 values of 60-190 µM, whereas a number of compounds inhibited TNFα-induced NF-κB activation with IC50 values in the range of 8-41 µM. Interestingly, three chalcones (nos. 10, 12 and 15) inhibited both TNFα-induced NF-κB activity and total HDAC activity of classes I, II and IV. Molecular …
Total citations
2012201320142015201620172018201920202021202220232024289714978812596
Scholar articles
B Orlikova, M Schnekenburger, M Zloh, F Golais… - Oncology reports, 2012